Reduced Serotonin-1A Receptor Binding in Social Anxiety Disorder

Biological Psychiatry

Volumn 61, Issue 9, 2007, Pages 1081-1089

  Lanzenberger, Rupert R ^a   Mitterhauser, Markus ^a,b   Spindelegger, Christoph ^a   Wadsak, Wolfgang ^a   Klein, Nikolas ^a   Mien, Leonhard Key ^a,b   Holik, Alexander ^a   Attarbaschi, Trawat ^a   Mossaheb, Nilufar ^a   Sacher, Julia ^a   Geiss Granadia, Thomas ^a   Kletter, Kurt ^a   Kasper, Siegfried ^a   Tauscher, Johannes ^a,c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

5 HT1A; Affective disorders; anxiety; PET; serotonin; social phobia; STAI

Indexed keywords

N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE CARBONYL C 11; RADIOPHARMACEUTICAL AGENT; SEROTONIN 1A RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AMYGDALOID NUCLEUS; ARTICLE; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; HUMAN; INSULA; LIMBIC CORTEX; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN BINDING; SCORING SYSTEM; SOCIAL PHOBIA;

ADULT; BRAIN; BRAIN CHEMISTRY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PHOBIC DISORDERS; PIPERAZINES; POSITRON-EMISSION TOMOGRAPHY; PSYCHIATRIC STATUS RATING SCALES; PYRIDINES; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN ANTAGONISTS;

EID: 34047252354     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2006.05.022     Document Type: Article

References (77)

1. Abrams J.K., Johnson P.L., Hollis J.H., and Lowry C.A. Anatomic and functional topography of the dorsal raphe nucleus. Ann N Y Acad Sci 1018 (2004) 46-57
2. Adolphs R. Neural systems for recognizing emotion. Curr Opin Neurobiol 12 (2002) 169-177
3. Adolphs R., Gosselin F., Buchanan T.W., Tranel D., Schyns P., and Damasio A.R. A mechanism for impaired fear recognition after amygdala damage. Nature 433 (2005) 68-72
4. Amargos-Bosch M., Bortolozzi A., Puig M.V., Serrats J., Adell A., Celada P., et al. Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex. Cereb Cortex 14 (2004) 281-299
5. Andrade T.G., Nakamuta J.S., Avanzi V., and Graeff F.G. Anxiolytic effect of estradiol in the median raphe nucleus mediated by 5-HT1A receptors. Behav Brain Res 163 (2005) 18-25
6. Bailer U.F., Frank G.K., Henry S.E., Price J.C., Meltzer C.C., Weissfeld L., et al. Altered brain serotonin 5-HT1A receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [carbonyl11C]WAY-100635. Arch Gen Psychiatry 62 (2005) 1032-1041
7. Benkelfat C., Bradwejn J., Meyer E., Ellenbogen M., Milot S., Gjedde A., et al. Functional neuroanatomy of CCK4-induced anxiety in normal healthy volunteers. Am J Psychiatry 152 (1995) 1180-1184
8. Bethea C.L., Lu N.Z., Gundlah C., and Streicher J.M. Diverse actions of ovarian steroids in the serotonin neural system. Front Neuroendocrinol 23 (2002) 41-100
9. Bethea C.L., Pau F.K., Fox S., Hess D.L., Berga S.L., and Cameron J.L. Sensitivity to stress-induced reproductive dysfunction linked to activity of the serotonin system. Fertil Steril 83 (2005) 148-155
10. Bhagwagar Z., Rabiner E.A., Sargent P.A., Grasby P.M., and Cowen P.J. Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635. Mol Psychiatry 9 (2004) 386-392
11. Birbaumer N., Grodd W., Diedrich O., Klose U., Erb M., Lotze M., et al. fMRI reveals amygdala activation to human faces in social phobics. Neuroreport 9 (1998) 1223-1226
12. Bishop S., Duncan J., Brett M., and Lawrence A.D. Prefrontal cortical function and anxiety: Controlling attention to threat-related stimuli. Nat Neurosci 7 (2004) 184-188
13. Blier P., and de Montigny C. Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders. Neuropsychopharmacology 21 suppl 2 (1999) 91S-98S
14. Bonne O., Bain E., Neumeister A., Nugent A.C., Vythilingam M., Carson R.E., et al. No change in serotonin type 1A receptor binding in patients with posttraumatic stress disorder. Am J Psychiatry 162 (2005) 383-385
15. Bouali S., Evrard A., Chastanet M., Lesch K.P., Hamon M., and Adrien J. Sex hormone-dependent desensitization of 5-HT1A autoreceptors in knockout mice deficient in the 5-HT transporter. Eur J Neurosci 18 (2003) 2203-2212
16. Bremner J.D., Bronen R.A., De Erasquin G., Vermetten E., Staib L.H., Ng C.K., et al. Development reliability of a method for using magnetic resonance imaging for the definition of regions of interest for position emission tomography. Clin Positron Imaging 1 (1998) 145-159
17. Burnet P.W., Eastwood S.L., and Harrison P.J. [3H]WAY-100635 for 5-HT1A receptor autoradiography in human brain: A comparison with [3H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia. Neurochem Int 30 (1997) 565-574
18. Celada P., Puig M.V., Casanovas J.M., Guillazo G., and Artigas F. Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: Involvement of serotonin-1A, GABA(A), and glutamate receptors. J Neurosci 21 (2001) 9917-9929
19. Celada P., Puig M.V., Martin-Ruiz R., Casanovas J.M., and Artigas F. Control of the serotonergic system by the medial prefrontal cortex: Potential role in the etiology of PTSD and depressive disorders. Neurotox Res 4 (2002) 409-419
20. Chua P., Krams M., Toni I., Passingham R., and Dolan R. A functional anatomy of anticipatory anxiety. Neuroimage 9 (1999) 563-571
21. Cleare A.J., Messa C., Rabiner E.A., and Grasby P.M. Brain 5-HT1A receptor binding in chronic fatigue syndrome measured using positron emission tomography and [11C]WAY-100635. Biol Psychiatry 57 (2005) 239-246
22. Delgado M., Caicoya A.G., Greciano V., Benhamu B., Lopez-Rodriguez M.L., Fernandez-Alfonso M.S., et al. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors. Eur J Pharmacol 511 (2005) 9-19
23. Drevets W.C., Frank E., Price J.C., Kupfer D.J., Holt D., Greer P.J., et al. PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry 46 (1999) 1375-1387
24. Fernandes C., McKittrick C.R., File S.E., and McEwen B.S. Decreased 5-HT1A and increased 5-HT2A receptor binding after chronic corticosterone associated with a behavioural indication of depression but not anxiety. Psychoneuroendocrinology 22 (1997) 477-491
25. Gross C., and Hen R. The developmental origins of anxiety. Nat Rev Neurosci 5 (2004) 545-552
26. Gross C., Santarelli L., Brunner D., Zhuang X., and Hen R. Altered fear circuits in 5-HT(1A) receptor KO mice. Biol Psychiatry 48 (2000) 1157-1163
27. Gross C., Zhuang X., Stark K., Ramboz S., Oosting R., Kirby L., et al. Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 416 (2002) 396-400
28. Gunn R.N., Sargent P.A., Bench C.J., Rabiner E.A., Osman S., Pike V.W., et al. Tracer kinetic modeling of the 5-HT1A receptor ligand [carbonyl-11C]WAY-100635 for PET. Neuroimage 8 (1998) 426-440
29. Hall H., Lundkvist C., Halldin C., Farde L., Pike V.W., McCarron J.A., et al. Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]way-100635. Brain Res 745 (1997) 96-108
30. Kalin N.H., and Shelton S.E. Nonhuman primate models to study anxiety, emotion regulation, and psychopathology. Ann N Y Acad Sci 1008 (2003) 189-200
31. Kalin N.H., Shelton S.E., and Davidson R.J. The role of the central nucleus of the amygdala in mediating fear and anxiety in the primate. J Neurosci 24 (2004) 5506-5515
32. Kalin N.H., Shelton S.E., Fox A.S., Oakes T.R., and Davidson R.J. Brain regions associated with the expression and contextual regulation of anxiety in primates. Biol Psychiatry 58 (2005) 796-804
33. Kent J.M., Coplan J.D., Mawlawi O., Martinez J.M., Browne S.T., Slifstein M., et al. Prediction of panic response to a respiratory stimulant by reduced orbitofrontal cerebral blood flow in panic disorder. Am J Psychiatry 162 (2005) 1379-1381
34. Kringelbach M.L. The human orbitofrontal cortex: Linking reward to hedonic experience. Nat Rev Neurosci 6 (2005) 691-702
35. Lammertsma A.A., and Hume S.P. Simplified reference tissue model for PET receptor studies. Neuroimage 4 (1996) 153-158
36. Liotti M., Mayberg H.S., Brannan S.K., McGinnis S., Jerabek P., and Fox P.T. Differential limbic-cortical correlates of sadness and anxiety in healthy subjects: Implications for affective disorders. Biol Psychiatry 48 (2000) 30-42
37. Lorberbaum J.P., Kose S., Johnson M.R., Arana G.W., Sullivan L.K., Hamner M.B., et al. Neural correlates of speech anticipatory anxiety in generalized social phobia. Neuroreport 15 (2004) 2701-2705
38. Martin-Ruiz R., Puig M.V., Celada P., Shapiro D.A., Roth B.L., Mengod G., et al. Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism. J Neurosci 21 (2001) 9856-9866
39. Matarrese M., Sudati F., Soloviev D., Todde S., Turolla E.A., Kienle M.G., et al. Automation of [11C]acyl chloride syntheses using commercially available 11C-modules. Appl Radiat Isot 57 (2002) 675-679
40. McCarron J.A., Turton D.R., Pike V.W., and Poole K.G. Remotely-controlled production of the 5-HT1A receptor radioligand, [carbonyl-11C]-WAY-100635, via 11Ccarboxylation of an immobilized Grignard reagent. J Labelled Comp Radiopharm 38 (1996) 941-953
41. Meijer O.C., and de Kloet E.R. Corticosterone and serotonergic neurotransmission in the hippocampus: Functional implications of central corticosteroid receptor diversity. Crit Rev Neurobiol 12 (1998) 1-20
42. Meijer O.C., Williamson A., Dallman M.F., and Pearce D. Transcriptional repression of the 5-HT1A receptor promoter by corticosterone via mineralocorticoid receptors depends on the cellular context. J Neuroendocrinol 12 (2000) 245-254
43. Meyer J.H., Gunn R.N., Myers R., Grasby P.M., et al. Assessment of spatial normalization of PET ligand images using ligand-specific templates. Neuroimage 9 (1999) 545-553
44. Mikolajczyk K., Szabatin M., Rudnicki P., Grodzki M., and Burger C. A JAVA environment for medical image data analysis: initial application for brain PET quatitation. Med Inform 23 (1998) 207-214 (Lond)
45. Milad M.R., and Quirk G.J. Neurons in medial prefrontal cortex signal memory for fear extinction. Nature 420 (2002) 70-74
46. Milad M.R., Vidal-Gonzalez I., and Quirk G.J. Electrical stimulation of medial prefrontal cortex reduces conditioned fear in a temporally specific manner. Behav Neurosci 118 (2004) 389-394
47. Morris J.S., Büchel C., and Dolan R.J. Parallel neural responses in amygdala subregions and sensory cortex during implicit fear conditioning. Neuroimage 13 (2001) 1044-1052
48. Neumeister A., Bain E., Nugent A.C., Carson R.E., Bonne O., Luckenbaugh D.A., et al. Reduced serotonin type 1A receptor binding in panic disorder. J Neurosci 24 (2004) 589-591
49. Parks C.L., Robinson P.S., Sibille E., Shenk T., and Toth M. Increased anxiety of mice lacking the serotonin1A receptor. Proc Natl Acad Sci U S A 95 (1998) 10734-10739
50. Parsey R.V., Oquendo M.A., Ogden R.T., Olvet D.M., Simpson N., Huang Y.Y., et al. Altered serotonin 1A binding in major depression: A [carbonyl-C-11]WAY100635 positron emission tomography study. Biol Psychiatry 59 2 (2006) 106-113
51. Parsey R.V., Oquendo M.A., Simpson N.R., Ogden R.T., Van Heertum R., Arango V., et al. Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using [C-11]WAY-100635. Brain Res 954 (2002) 173-182
52. Parsey R.V., Slifstein M., Hwang D.R., Abi-Dargham A., Simpson N., Mawlawi O., et al. Validation and reproducibility of measurement of 5-HT1A receptor parameters with [carbonyl-11C]WAY-100635 in humans: Comparison of arterial and reference tissue input functions. J Cereb Blood Flow Metab 20 (2000) 1111-1133
53. Pine D.S., Fyer A., Grun J., Phelps E.A., Szeszko P.R., Koda V., et al. Methods for developmental studies of fear conditioning circuitry. Biol Psychiatry 50 (2001) 225-228
54. Puig M.V., Artigas F., and Celada P. Modulation of the activity of pyramidal neurons in rat prefrontal cortex by raphe stimulation in vivo: Involvement of serotonin and GABA. Cereb Cortex 15 (2005) 1-14
55. Rabiner E.A., Bhagwagar Z., Gunn R.N., Cowen P.J., and Grasby P.M. Preferential 5-HT1A autoreceptor occupancy by pindolol is attenuated in depressed patients: Effect of treatment or an endophenotype of depression?. Neuropsychopharmacology 29 (2004) 1688-1698
56. Rabiner E.A., Gunn R.N., Wilkins M.R., Sargent P.A., Mocaer E., Sedman E., et al. Drug action at the 5-HT(1A) receptor in vivo: Autoreceptor and postsynaptic receptor occupancy examined with PET and [carbonyl-(11)C]WAY-100635. Nucl Med Biol 27 (2000) 509-513
57. Rabiner E.A., Messa C., Sargent P.A., Husted-Kjaer K., Montgomery A., Lawrence A.D., et al. A database of [(11)C]WAY-100635 binding to 5-HT(1A) receptors in normal male volunteers: Normative data and relationship to methodological, demographic, physiological, and behavioral variables. Neuroimage 15 (2002) 620-632
58. Ramboz S., Oosting R., Amara D.A., Kung H.F., Blier P., Mendelsohn M., et al. Serotonin receptor 1A knockout: An animal model of anxiety-related disorder. Proc Natl Acad Sci U S A 95 (1998) 14476-14481
59. Riad M., Zimmer L., Rbah L., Watkins K.C., Hamon M., and Descarries L. Acute treatment with the antidepressant fluoxetine internalizes 5-HT1A autoreceptors and reduces the in vivo binding of the PET radioligand [18F]MPPF in the nucleus raphe dorsalis of rat. J Neurosci 24 (2004) 5420-5426
60. Robinson S., Hoheisel B., Windischberger C., Habel U., and Lanzenberger R. FMRI of the emotions: Towards an improved understanding of amygdala function. Current Medical Imaging Reviews 1 (2005) 115-129
61. Santana N., Bortolozzi A., Serrats J., Mengod G., and Artigas F. Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. Cereb Cortex 14 (2004) 1100-1109
62. Sargent P.A., Kjaer K.H., Bench C.J., Rabiner E.A., Messa C., Meyer J., et al. Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: Effects of depression and antidepressant treatment. Arch Gen Psychiatry 57 (2000) 174-180
63. Schneider F., Weiss U., Kessler C., Muller-Gartner H.W., Posse S., Salloum J.B., et al. Subcortical correlates of differential classical conditioning of aversive emotional reactions in social phobia. Biol Psychiatry 45 (1999) 863-871
64. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59 Suppl 20 (1998) 22-33 quiz 34-57.
65. Shin L.M., Wright C.I., Cannistraro P.A., Wedig M.M., McMullin K., Martis B., et al. A functional magnetic resonance imaging study of amygdala and medial prefrontal cortex responses to overtly presented fearful faces in posttraumatic stress disorder. Arch Gen Psychiatry 62 (2005) 273-281
66. Spielberger C.D., and Vagg P.R. Psychometric properties of the STAI: A reply to Ramanaiah, Franzen, and Schill. J Pers Assess 48 (1984) 95-97
67. Stein M.B., Goldin P.R., Sareen J., Zorrilla L.T., and Brown G.G. Increased amygdala activation to angry and contemptuous faces in generalized social phobia. Arch Gen Psychiatry 59 (2002) 1027-1034
68. Sullivan G.M., Oquendo M.A., Simpson N., Van Heertum R.L., John Mann J., and Parsey R.V. Brain serotonin(1A) receptor binding in major depression is related to psychic and somatic anxiety. Biol Psychiatry 58 12 (2005) 947-954
69. Talbot P.S. The molecular neuroimaging of anxiety disorders. Curr Psychiatry Rep 6 (2004) 274-279
70. Tauscher J., Bagby R.M., Javanmard M., Christensen B.K., Kasper S., and Kapur S. Inverse relationship between serotonin 5-HT(1A) receptor binding and anxiety: A [(11)C]WAY-100635 PET investigation in healthy volunteers. Am J Psychiatry 158 (2001) 1326-1328
71. Tauscher J., Kapur S., Verhoeff N.P., Hussey D.F., Daskalakis Z.J., Tauscher-Wisniewski S., et al. Brain serotonin 5-HT(1A) receptor binding in schizophrenia measured by positron emission tomography and [11C]WAY-100635. Arch Gen Psychiatry 59 (2002) 514-520
72. Tauscher J., Verhoeff N.P., Christensen B.K., Hussey D., Meyer J.H., Kecojevic A., et al. Serotonin 5-HT1A receptor binding potential declines with age as measured by [11C]WAY-100635 and PET. Neuropsychopharmacology 24 (2001) 522-530
73. Tillfors M., Furmark T., Marteinsdottir I., Fischer H., Pissiota A., Langstrom B., et al. Cerebral blood flow in subjects with social phobia during stressful speaking tasks: A PET study. Am J Psychiatry 158 (2001) 1220-1226
74. Tillfors M., Furmark T., Marteinsdottir I., and Fredrikson M. Cerebral blood flow during anticipation of public speaking in social phobia: A PET study. Biol Psychiatry 52 (2002) 1113-1119
75. Varnas K., Halldin C., and Hall H. Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain. Hum Brain Mapp 22 (2004) 246-260
76. Veit R., Flor H., Erb M., Hermann C., Lotze M., Grodd W., et al. Brain circuits involved in emotional learning in antisocial behavior and social phobia in humans. Neurosci Lett 328 (2002) 233-236
77. Wright C.I., Martis B., McMullin K., Shin L.M., and Rauch S.L. Amygdala and insular responses to emotionally valenced human faces in small animal specific phobia. Biol Psychiatry 54 (2003) 1067-1076